Biotherapeutics Antibody for the Treatment of Solid Cancers

BioTherapeutics is focused on developing innovative antibody-based cancer treatments, based on a range of proprietary technologies. These target a number of oncology indications, with a particular focus on cancers with limited treatment options. These include a mixture of solid and liquid malignancies, such as acute myeloid leukemia and breast, ovarian and lung cancers. Monoclonal antibodies have emerged as a class of novel oncology therapeutics. 

The selectivity and specificity, the unique pharmacokinetics, and the ability to engage and activate the immune system differentiate these biologics from traditional small molecule anticancer drugs.

  • Advances in bispecific biotherapeutics for the treatment of cancer
  • Antibody-drug conjugates for cancer therapy
  • Angiogenesis inhibitor antibodies
  • Biotherapeutic approaches to target cancer stem cells

Related Conference of Biotherapeutics Antibody for the Treatment of Solid Cancers

Biotherapeutics Antibody for the Treatment of Solid Cancers Conference Speakers